Surgery in early metastatic seminoma is a prospective phase II single-arm, multi-institutional trial of RPLND as first-line treatment for testicular seminoma with clinically low-volume retroperitoneal ...
Men with nonseminomatous germ cell tumors (NSGCTs) who are at high risk of metastasis can benefit from retroperitoneal lymph node dissection (RPLND) as primary treatment, a recent study from Harvard ...
Multifocal Ductal Carcinoma In Situ of the Breast: A Contraindication for Breast-Conserving Treatment? The prospect of primary chemotherapy to eradicate virtually all low- or limited volume ...
Please can you give a brief introduction to robotic RPLND and how this procedure has traditionally been performed? Robotic RPLND utilizes laparoscopy combined with robotic technology to perform ...
On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
SAN FRANCISCO — Retroperitoneal lymph node dissection (RPLND) could potentially be a first-line option for men with stage II A/B testicular seminoma in order to reduce long-term toxicity and secondary ...
The appropriate integration of surgery and chemotherapy in the management of non-seminomatous germ-cell tumors (NSGCT) has resulted in overall survival rates of over 90% for all stages of the disease.
A minimally invasive robotic surgery was successfully carried out in the city on a 27-year-old youth, who was diagnosed with testicular cancer, to remove lymph nodes behind his intestines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results